Canada’s ability to develop and manufacture advanced therapies is both a health and national security asset. #ATIAP would build capabilities that serve patients every day and strengthen Canada’s readiness for emergencies.

Learn more: stemcellnetwork.ca/wp-content/u... #cdnpoli

Since 2020, Canada has invested over $2.5B in #biomanufacturing, vaccine & therapeutics projects. #ATIAP would help turn that investment into productive economic activity by preparing Cdn products, companies and workers to use it.

Learn more. ➡️ stemcellnetwork.ca/wp-content/u... #cdnpoli

Canada needs to invest in its own #biotech companies so more Canadian talent, IP & economic benefits remain here. Without action, we will continue to take the early scientific risk while other countries capture the commercial return.

How #ATIAP can help: stemcellnetwork.ca/wp-content/u...